Results 1 to 10 of about 4,956 (112)
Frontiers in Cellular and Infection Microbiology, 2022 Coronavirus disease 2019 (COVID-19) pandemic has killed huge populations throughout the world and acts as a high-risk factor for elderly and young immune-suppressed patients.
Manali Singh +16 more
doaj +1 more source
NAJFNR, 2022 Background: Withania somnifera has been used as an ergogenic resource in recent years. In this scenario, a systematic literature review is justified to compile the findings in the scientific literature and to evaluate the methodological quality of these
Fábio Pieluhowski Didio +2 more
doaj +1 more source
Evaluation of Analgesic Activity of Standardised Aqueous Extract of Withania somnifera in Healthy Human Volunteers using Mechanical Pain Model [PDF]
Journal of Clinical and Diagnostic Research, 2019 Introduction: Drugs commonly used for pain management are associated with adverse effects. Experimental pain models in human healthy volunteers are advantageous for early evaluation of analgesics. Studies with Withania somnifera have demonstrated that it
Manjunath Nookala Krishna murthy +3 more
doaj +1 more source
Virology Journal, 2023 Background Several anti-retroviral drugs are available against Human immunodeficiency virus type-1, but have multiple adverse side effects. Hence, there is an incessant compulsion for effectual anti-retroviral agents with minimal or no intricacy ...
Pratiksha Jadaun +8 more
doaj +1 more source
Evaluating anticancer properties of Withaferin A—a potent phytochemical
Frontiers in Pharmacology, 2022 Withaferin A is a C28 steroidal lactone derived from the plant Withania somnifera, commonly known as Ashwagandha. Withaferin A has received great attention for its anticancer properties noted in cancer cells of various origins.
Maushma Atteeq
doaj +1 more source
QUANTITIVE EVOLUTION OF WITHANOLIDES CONTENT OF EGYPTIAN WITHANIA SOMNIFERA (L.) ROOTS. [PDF]
Al-Azhar Journal of Pharmaceutical Sciences, 2013 Withanolides are important secondary metabolite in Withania somnifera (L.), which have high medicinal values and possess potent anti-tumor and antioxidant properties.
Said Ismail
doaj +1 more source
RNAi and Homologous Over-Expression Based Functional Approaches Reveal Triterpenoid Synthase Gene-Cycloartenol Synthase Is Involved in Downstream Withanolide Biosynthesis in Withania somnifera. [PDF]
PLoS ONE, 2016 Withania somnifera Dunal, is one of the most commonly used medicinal plant in Ayurvedic and indigenous medicine traditionally owing to its therapeutic potential, because of major chemical constituents, withanolides.
Smrati Mishra +6 more
doaj +1 more source
International Journal of Electrochemical Science, 2019 Corrosion inhibitive effect of Withania Somnifera extract has been studied in 0.5 M nitric acid for Copper (Cu). The studies were done at different temperatures (30-50oC). The thermodynamic parameters were determined. Withania Somnifera has been found to
H.M. Elabbasy
doaj +1 more source
The immunomodulatory role of withania somnifera (L.) dunal in inflammatory diseases
Frontiers in Pharmacology, 2023 Withania somnifera (L.) Dunal (Solanaceae) (also known as Ashwagandha) is a botanical drug that has been used for centuries to treat many chronic diseases like high blood pressure, arthritis, diabetes, Alzheimer’s disease, and depression.
Hamad H. Alanazi, Elyasa Elfaki
doaj +1 more source
Journal of Animal Science and Technology, 2018 Infectious Bursal Disease is a severe viral disease of chicken responsible for serious economic losses to poultry farmers. The causative agent, Infectious Bursal Disease virus, is inhibited by nitric oxide.
Bhaskar Ganguly +2 more
doaj +1 more source